DK0610357T3 - Transdermale, terapeutiske systemer med krystallisationsinhibitorer - Google Patents

Transdermale, terapeutiske systemer med krystallisationsinhibitorer

Info

Publication number
DK0610357T3
DK0610357T3 DK92922822.9T DK92922822T DK0610357T3 DK 0610357 T3 DK0610357 T3 DK 0610357T3 DK 92922822 T DK92922822 T DK 92922822T DK 0610357 T3 DK0610357 T3 DK 0610357T3
Authority
DK
Denmark
Prior art keywords
transdermal therapeutic
therapeutic systems
crystallization inhibitors
crystallization
inhibitors
Prior art date
Application number
DK92922822.9T
Other languages
Danish (da)
English (en)
Inventor
Ralph Lipp
Jutta Riedl
Johannes Tack
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Application granted granted Critical
Publication of DK0610357T3 publication Critical patent/DK0610357T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK92922822.9T 1991-10-31 1992-10-21 Transdermale, terapeutiske systemer med krystallisationsinhibitorer DK0610357T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4136057 1991-10-31
DE4210711A DE4210711A1 (de) 1991-10-31 1992-03-27 Transdermale therapeutische systeme mit kristallisationsinhibitoren

Publications (1)

Publication Number Publication Date
DK0610357T3 true DK0610357T3 (da) 1998-05-11

Family

ID=25908725

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92922822.9T DK0610357T3 (da) 1991-10-31 1992-10-21 Transdermale, terapeutiske systemer med krystallisationsinhibitorer

Country Status (14)

Country Link
EP (1) EP0610357B1 (enrdf_load_stackoverflow)
JP (1) JP3526864B2 (enrdf_load_stackoverflow)
AT (1) ATE158181T1 (enrdf_load_stackoverflow)
AU (2) AU2895392A (enrdf_load_stackoverflow)
CA (1) CA2120599C (enrdf_load_stackoverflow)
DE (2) DE4210711A1 (enrdf_load_stackoverflow)
DK (1) DK0610357T3 (enrdf_load_stackoverflow)
ES (1) ES2106888T3 (enrdf_load_stackoverflow)
FI (1) FI110061B (enrdf_load_stackoverflow)
GR (1) GR3025237T3 (enrdf_load_stackoverflow)
HU (1) HU227531B1 (enrdf_load_stackoverflow)
NO (1) NO307644B1 (enrdf_load_stackoverflow)
PT (1) PT101019B (enrdf_load_stackoverflow)
WO (1) WO1993008795A1 (enrdf_load_stackoverflow)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
ATE149349T1 (de) * 1993-06-25 1997-03-15 Alza Corp Einarbeitung eines poly-n-vinylamids in ein transdermales system
DE4333595A1 (de) * 1993-10-01 1995-04-06 Labtec Gmbh Transdermales therapeutisches System zur Applikation von Arzneimitteln auf die Haut
DE4405899A1 (de) * 1994-02-18 1995-08-24 Schering Ag Mittel zur transdermalen Applikation enthaltend Desogestrel
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Preparations given through the skin of unstable anti-acid drugs
US6024974A (en) * 1995-01-06 2000-02-15 Noven Pharmaceuticals, Inc. Composition and methods for transdermal delivery of acid labile drugs
DE19500662C2 (de) * 1995-01-12 2001-04-26 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster und seine Verwendung
US5698217A (en) * 1995-05-31 1997-12-16 Minnesota Mining And Manufacturing Company Transdermal drug delivery device containing a desiccant
CZ292151B6 (cs) † 1995-06-07 2003-08-13 Ortho-Mcneil Pharmaceutical, Inc. Transdermální náplast pro podávání 17-deacetylnorgestimátu samotného nebo v kombinaci s estrogenem
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
US5702720A (en) * 1995-12-22 1997-12-30 Minnesota Mining And Manufacturing Company Transdermal device for the delivery of flurbiprofen
DE19629468A1 (de) * 1996-07-11 1998-01-15 Schering Ag Transdermale therapeutische Systeme
DE19649535C2 (de) * 1996-11-29 2000-02-10 Lohmann Therapie Syst Lts Verfahren zur Herstellung eines pflasterförmigen therapeutischen Systems
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
GB9720470D0 (en) * 1997-09-25 1997-11-26 Ethical Pharmaceuticals South Inhibition of crystallization in transdermal devices
DE19827732A1 (de) * 1998-06-22 1999-12-23 Rottapharm Bv Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie
DE19829713C1 (de) * 1998-07-03 2000-01-05 Lohmann Therapie Syst Lts Therapeutisches System mit Zusatz von Perglanzpigmenten
DE19834006A1 (de) * 1998-07-29 2000-02-24 Lohmann Therapie Syst Lts Estradiolhaltiges Pflaster zur transdermalen Applikation von Hormonen
DE19843027A1 (de) * 1998-09-19 2000-03-23 Labtec Gmbh Neohesperidin DC als Kristallisationsinhibitor
DK1233763T3 (da) * 1999-11-29 2003-10-20 Lohmann Therapie Syst Lts Transdermale terapeutiske systemer med forbedret stabilitet og en fremgangsmåde til deres fremstilling
DE10012908B4 (de) * 2000-03-16 2005-03-17 Lts Lohmann Therapie-Systeme Ag Stabilisierte übersättigte transdermale therapeutische Matrixsysteme und Verfahren zu ihrer Herstellung
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
NZ530227A (en) * 2001-06-18 2006-09-29 Noven Pharma Enhanced drug delivery in transdermal systems
AU2004283431B2 (en) 2003-10-10 2009-09-10 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
US8431152B2 (en) 2005-02-28 2013-04-30 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
US9155725B2 (en) 2008-02-27 2015-10-13 Hisamitsu Pharmaceutical Co., Inc. Adhesive skin patch and packaged product
US8580281B2 (en) 2008-02-27 2013-11-12 Hisamitsu Pharmaceutical Co., Inc. Medicated patch
EP2258396B1 (en) 2008-03-03 2017-09-06 Hisamitsu Pharmaceutical Co., Inc. Transdermally absorbable preparation
JP5766475B2 (ja) * 2010-03-30 2015-08-19 日東電工株式会社 貼付製剤およびその製造方法
DE102010040299A1 (de) 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
ES2958185T3 (es) 2013-09-11 2024-02-05 Medrx Co Ltd Nueva composición para material de base de apósito en una preparación de esparadrapo

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8512358D0 (en) * 1985-05-16 1985-06-19 Euro Celtique Sa Transdermal delivery system
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
DE3933460A1 (de) * 1989-10-06 1991-04-18 Lohmann Therapie Syst Lts Oestrogenhaltiges wirkstoffpflaster
WO1991005529A1 (en) * 1989-10-13 1991-05-02 Watson Laboratories, Inc. Drug delivery systems and matrix therefor
JPH07116032B2 (ja) * 1990-04-06 1995-12-13 積水化学工業株式会社 ニトログリセリン貼付剤

Also Published As

Publication number Publication date
HU9401257D0 (en) 1994-08-29
NO941593D0 (enrdf_load_stackoverflow) 1994-04-29
FI942011A0 (fi) 1994-04-29
HU227531B1 (en) 2011-07-28
AU2895392A (en) 1993-06-07
FI942011L (fi) 1994-04-29
EP0610357A1 (de) 1994-08-17
JPH07506083A (ja) 1995-07-06
JP3526864B2 (ja) 2004-05-17
AU712692B2 (en) 1999-11-11
EP0610357B1 (de) 1997-09-17
PT101019B (pt) 1999-10-29
NO941593L (no) 1994-04-29
DE59208918D1 (de) 1997-10-23
ATE158181T1 (de) 1997-10-15
AU1652997A (en) 1997-05-29
NO307644B1 (no) 2000-05-08
WO1993008795A1 (de) 1993-05-13
CA2120599C (en) 2003-04-15
CA2120599A1 (en) 1993-05-13
DE4210711A1 (de) 1993-05-06
GR3025237T3 (en) 1998-02-27
ES2106888T3 (es) 1997-11-16
PT101019A (pt) 1994-02-28
HUT72964A (en) 1996-06-28
FI110061B (fi) 2002-11-29

Similar Documents

Publication Publication Date Title
DK0610357T3 (da) Transdermale, terapeutiske systemer med krystallisationsinhibitorer
FI940427A0 (fi) Ihon läpi vaikuttavia terapeuttisia systeemejä
ATE200028T1 (de) Transdermale abgabe vorrichtung
DK0744944T3 (da) Transdermale terapeutiske systemer indeholdende kønssterioder
DK0817622T3 (da) Transdermalt applicerbart lægemiddel med ACE-hæmmere
MY109727A (en) Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals
ITTO960469A0 (it) Dispositivo per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
ATE209940T1 (de) Verbesserte transdermale vorrichtung mit verringerter delaminierung
ITTO960477A0 (it) Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
ATE293960T1 (de) Transdermale vorrichtung zur verabreichungvon von testosteron
FI961282L (fi) Transdermaalinen terapeuttinen systeemi, jossa on asetyylisalisyylihappo vaikuttavana aineena
ITTO960488A0 (it) Dispositivo e procedimento per la somministrazione transdermica mediante elettrotrasporto di fentanil e sufentanil.
GR1000318B (el) Θεραπευτικως δραστικη υποκατεστημενη βενζιμιδαζολη και μεθοδος για την παρασκευη αυτης.
DK0650359T3 (da) Transdermalt terapeutisk system med det aktive stof 17-beta-estradiol (vandfrit)
DK0794770T3 (da) Transdermalt præparat indeholdende en loratidin-metabolit med antihistaminvirkning
ATE289818T1 (de) Transdermales therapeutisches system mit einer östriol enthaltenden bisphosphatekombination